Artelo Biosciences, Inc.
ARTL
$5.98
-$0.21-3.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.20M | 10.27M | 600.00K | 1.72M | 2.07M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 173.00K | 148.00K | 95.00K | 107.00K | 167.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.37M | 10.42M | 695.00K | 1.83M | 2.23M |
|
|
|||||
| Total Current Assets | 4.37M | 10.42M | 695.00K | 1.83M | 2.23M |
| Net Property, Plant & Equipment | 46.00K | 55.00K | 64.00K | 73.00K | 82.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.00K | 3.00K | 3.00K | 328.00K | 3.00K |
| Total Assets | 6.46M | 12.52M | 2.80M | 4.27M | 4.36M |
|
|
|||||
| Total Accounts Payable | 1.30M | 4.04M | 3.04M | 3.87M | 4.84M |
| Total Accrued Expenses | 111.00K | 504.00K | 359.00K | 78.00K | 44.00K |
| Short-term Debt | -- | 660.00K | 609.00K | 875.00K | 791.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 42.00K | 41.00K | 40.00K | 39.00K | 36.00K |
| Total Finance Division Other Current Liabilities | -- | 582.00K | 1.00K | -- | -- |
| Total Other Current Liabilities | -- | 582.00K | 1.00K | -- | -- |
| Total Current Liabilities | 1.46M | 5.83M | 4.04M | 4.86M | 5.71M |
|
|
|||||
| Total Current Liabilities | 1.46M | 5.83M | 4.04M | 4.86M | 5.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 660.00K | 609.00K | 875.00K | 791.00K |
| Capital Leases | 7.00K | 18.00K | 29.00K | 40.00K | 51.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.46M | 5.85M | 4.07M | 4.90M | 5.76M |
|
|
|||||
| Common Stock & APIC | 73.64M | 72.89M | 62.02M | 58.49M | 54.62M |
| Retained Earnings | -68.40M | -65.97M | -63.02M | -58.85M | -55.73M |
| Treasury Stock & Other | -242.00K | -246.00K | -272.00K | -277.00K | -295.00K |
| Total Common Equity | 5.00M | 6.67M | -1.27M | -633.00K | -1.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.00M | 6.67M | -1.27M | -633.00K | -1.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.00M | 6.67M | -1.27M | -633.00K | -1.41M |
|
|
|||||